5don MSN
No more guesswork in drug design—atomic-resolution method exposes what trial and error keep missing
Drug discovery still too often relies on expensive trial and error. Researchers from ICTER show there is another way—building ...
A team of chemists has unveiled a novel method to simplify the synthesis of piperidines, a key structural component in many pharmaceuticals. The study combines biocatalytic carbon-hydrogen oxidation ...
In the search for new drugs, artificial intelligence in the form of diffusion models is being used in drug design. What ...
This allows scientists to build drug molecules step-by-step and directly observe their binding to targets at atomic resolution. Similar to how UCLA’s SEE-CITE method maps binding sites with precision, ...
LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus”), a leading provider of biosimulation, simulation-enabled performance and intelligence solutions, and ...
Disease modeling and target identification are critical and time-consuming portions of the drug discovery process and areas where artificial intelligence (AI) is already making a substantial impact. A ...
Researchers at the Institute of Science Tokyo have developed a simple and efficient method for synthesizing ...
Experts have been raising concerns about “AI washing.” One of these experts, futurist Bernard Marr, has said that AI washing “involves exaggerating the capabilities of a product or service that is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results